Beximco sends Bemsivir to Pakistan for some Covid-19 patients

Sun Online Desk

2nd June, 2020 03:03:34 printer

Beximco sends Bemsivir to Pakistan for some Covid-19 patients

Beximco Pharmaceuticals on Sunday sent some antiviral medicine to Pakistan by a special cargo flight for treating dome critically ill Covid-19 patients.

A spokesperson of Beximco said the medicine was sent to Pakistan on request of the Pakistan High Commission in Dhaka for three critically ill Covid-19 patients.

"On humanitarian considerations, Beximco sent 48 vials/injections of Bemsivir to Pakistan," the spokesperson said.

Being requested by official authorities to provide Bemsivir for a small group of critically ill patients, Beximco carried out this act against special import permit issued by Pakistan's Drug Regulatory Authority.

Bemsivir is the world's first approved generic Remdesivir produced by Bangladeshi Pharmaceutical Company Beximco.

Group Captain AHM Touhid-ul Ahsan, director of Hazrat Shahjalal International Airport (HSIA), told media that the cargo aircraft landed at the airport at 8:30 pm on Sunday and departed at 10:03 pm.

Recently, Pakistani pharmaceutical company Searle Pharma announced that it plans to import the antiviral drug Remdesivir from Bangladesh, which has shown promise in treating coronavirus patients.

The firm said it had entered into an exclusive licensing and marketing agreement with Bangladesh's Beximco Pharmaceuticals.

"Searle Pharma is planning to import Remdesivir in finished form (ready to use) to meet the country's urgent requirements," the company told the Pakistan Stock Exchange.

Remdesivir, a drug developed by Gilead Sciences, has grabbed attention as one of the most promising treatments for Covid-19.